Murine CD8 +T cell cytotoxicity against schistosomula induced by inoculation of schistosomal 22.6/26GST coupled Sepharose 4B beads

Vaccine

Volumn 30, Issue 14, 2012, Pages 2440-2447

  Zhou, Ying ^a,b   Zhang, Hui ^c   Sun, Xin Juan ^a   Zheng, Dan ^a   Liang, Yue Jin ^a   Luo, Jie ^a   Wang, Yong ^a   Zhang, Zhao Song ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b Jiangsu Provincial Centre for Disease Prevention and Control   (China)

^c CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

CD8 +T cells; Cross presentation; Schistosoma japonicum; Sepharose 4B

Indexed keywords

26GST PARTICULATE ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PARASITE ANTIGEN; SCHISTOSOMA VACCINE; SEPHAROSE; SJ22.6 PARTICULATE ANTIGEN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD8+ T LYMPHOCYTE; CELL STIMULATION; CONTROLLED STUDY; CROSS PRESENTATION; CYTOTOXICITY; DENDRITIC CELL; FEMALE; INOCULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCHISTOSOMA JAPONICUM; SCHISTOSOMIASIS JAPONICA; SCHISTOSOMULUM; VACCINATION; WORM INFECTION;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, HELMINTH; CYTOTOXICITY, IMMUNOLOGIC; DENDRITIC CELLS; FEMALE; FREUND'S ADJUVANT; HELMINTH PROTEINS; MICE; MICE, INBRED BALB C; SCHISTOSOMA JAPONICUM; SCHISTOSOMIASIS; SEPHAROSE; T-LYMPHOCYTES, CYTOTOXIC; VACCINES;

EID: 84862802450     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.01.068     Document Type: Article

References (45)

1. Farah I.O., Johansson M., Lovgren-Bengtson K., Hau J. Schistosoma mansoni in mice: the pattern of primary cercarial exposure determines whether a secondary infection post-chemotherapy elicits a T helper 1- or a T helper 2-associated immune response. Scand J Immunol 2000, 51(March (3)):237-243.
2. McManus D.P., Loukas A. Current status of vaccines for schistosomiasis. Clin Microbiol Rev 2008, 21(January (1)):225-242.
3. Jiz M., Wu H.W., Meng R., Pond-Tor S., Reynolds M., Friedman J.F., et al. Pilot-scale production and characterization of paramyosin, a vaccine candidate for schistosomiasis japonica. Infect Immun 2008, 76(July (7)):3164-3169.
4. Dai Y., Zhu Y., Harn D.A., Wang X., Tang J., Zhao S., et al. DNA vaccination by electroporation and boosting with recombinant proteins enhances the efficacy of DNA vaccines for Schistosomiasis japonica. Clin Vaccine Immunol 2009, 16(December (12)):1796-1803.
5. Pearce E.J., James S.L., Hieny S., Lanar D.E., Sher A. Induction of protective immunity against Schistosoma mansoni by vaccination with schistosome paramyosin (Sm97), a nonsurface parasite antigen. Proc Natl Acad Sci USA 1988, 85(August (15)):5678-5682.
6. Ahmad G., Torben W., Zhang W., Wyatt M., Siddiqui A.A. Sm-p80-based DNA vaccine formulation induces potent protective immunity against Schistosoma mansoni. Parasite Immunol 2009, 31(March (3)):156-161.
7. Tian F., Lin D., Wu J., Gao Y., Zhang D., Ji M., et al. Immune events associated with high level protection against Schistosoma japonicum infection in pigs immunized with UV-attenuated cercariae. PLoS One 2010, 5(10):e13408.
8. +T-cell count ratios, and antibody levels in migrant fishermen infected with Schistosoma japonicum in the Dongting Lake, China. Am J Trop Med Hyg 2006, 75(November (5)):910-913.
9. Brown M., Miiro G., Nkurunziza P., Watera C., Quigley M.A., Dunne D.W., et al. Schistosoma mansoni, nematode infections, and progression to active tuberculosis among HIV-1-infected Ugandans. Am J Trop Med Hyg 2006, 74(May (5)):819-825.
10. Kamal S.M., Bianchi L., Al Tawil A., Koziel M., El Sayed Khalifa K., Peter T., et al. Specific cellular immune response and cytokine patterns in patients coinfected with hepatitis C virus and Schistosoma mansoni. J Infect Dis 2001, 184(October (8)):972-982.
11. Yang W., Jackson D.C., Zeng Q., McManus D.P. Multi-epitope schistosome vaccine candidates tested for protective immunogenicity in mice. Vaccine 2000, 19(August (1)):103-113.
12. Waeckerle-Men Y., Groettrup M. PLGA microspheres for improved antigen delivery to dendritic cells as cellular vaccines. Adv Drug Deliv Rev 2005, 57(January (3)):475-482.
13. Nayak J.V., Hokey D.A., Larregina A., He Y., Salter R.D., Watkins S.C., et al. Phagocytosis induces lysosome remodeling and regulated presentation of particulate antigens by activated dendritic cells. J Immunol 2006, 177(December (12)):8493-8503.
14. +T cells. Cell Death Differ 2009, 16(July (7)):991-1005.
15. Lipscomb M.F., Masten B.J. Dendritic cells: immune regulators in health and disease. Physiol Rev 2002, 82(January (1)):97-130.
16. Farag M.M., Hoyler B., Encke J., Stremmel W., Weigand K. Dendritic cells can effectively be pulsed by HBVsvp and induce specific immune reactions in mice. Vaccine 2010, 29(December (2)):200-206.
17. Goforth R., Salem A.K., Zhu X., Miles S., Zhang X.Q., Lee J.H., et al. Immune stimulatory antigen loaded particles combined with depletion of regulatory T-cells induce potent tumor specific immunity in a mouse model of melanoma. Cancer Immunol Immunother 2009, 58(April (4)):517-530.
18. Willart M.A., Jan de Heer H., Hammad H., Soullie T., Deswarte K., Clausen B.E., et al. The lung vascular filter as a site of immune induction for T cell responses to large embolic antigen. J Exp Med 2009, 206(November (12)):2823-2835.
19. Duvall R.H., DeWitt W.B. An improved perfusion technique for recovering adult schistosomes from laboratory animals. Am J Trop Med Hyg 1967, 16(July (4)):483-486.
20. Cook R.M., Carvalho-Queiroz C., Wilding G., LoVerde P.T. Nucleic acid vaccination with Schistosoma mansoni antioxidant enzyme cytosolic superoxide dismutase and the structural protein filamin confers protection against the adult worm stage. Infect Immun 2004, 72(October (10)):6112-6124.
21. Jiang S., Qiu Q., He Y., Wei M. Killing effects of fractional proteins from Microtu fortis serum on Schistosoma japonicum schistosomula in vitro. Chin J Schisto Control 2008, 20(April (4)):260-264.
22. Chanova M., Bulantova J., Maslo P., Horak P. In vitro cultivation of early schistosomula of nasal and visceral bird schistosomes (Trichobilharzia spp., Schistosomatidae). Parasitol Res 2009, 104(June (6)):1445-1452.
23. Lutz M.B., Kukutsch N., Ogilvie A.L., Rossner S., Koch F., Romani N., et al. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J Immunol Methods 1999, 223(February (1)):77-92.
24. Son Y.I., Egawa S., Tatsumi T., Redlinger R.E., Kalinski P., Kanto T. A novel bulk-culture method for generating mature dendritic cells from mouse bone marrow cells. J Immunol Methods 2002, 262(April (1-2)):145-157.
25. Hou W.S., Van Parijs L. A Bcl-2-dependent molecular timer regulates the lifespan and immunogenicity of dendritic cells. Nat Immunol 2004, 5(June (6)):583-589.
26. Li Y., Ye J., Yang X., Xu M., Chen L., Mei L., et al. Infection of mouse bone marrow-derived dendritic cells by live attenuated Japanese encephalitis virus induces cells maturation and triggers T cells activation. Vaccine 2011, 29(January (4)):855-862.
27. Waine G.J., Becker M.M., Scott J.C., Kalinna B.H., Yang W., McManus D.P. Purification of a recombinant Schistosoma japonicum antigen homologous to the 22-kDa membrane-associated antigen of S. mansoni, a putative vaccine candidate against schistosomiasis. Gene 1994, 142(May (2)):259-263.
28. Datta S.K., Redecke V., Prilliman K.R., Takabayashi K., Corr M., Tallant T., et al. A subset of Toll-like receptor ligands induces cross-presentation by bone marrow-derived dendritic cells. J Immunol 2003, 170(April (8)):4102-4110.
29. Wooldridge L., Clement M., Lissina A., Edwards E.S., Ladell K., Ekeruche J., et al. MHC class I molecules with superenhanced CD8 binding properties bypass the requirement for cognate TCR recognition and nonspecifically activate CTLs. J Immunol 2010, 184(April (7)):3357-3366.
30. Lau A.W., Chou M.M. The adaptor complex AP-2 regulates post-endocytic trafficking through the non-clathrin Arf6-dependent endocytic pathway. J Cell Sci 2008, 121(December (Pt 24)):4008-4017.
31. +T cells. J Immunol 2005, 175(December (11)):7093-7097.
32. Revell P.A., Grossman W.J., Thomas D.A., Cao X., Behl R., Ratner J.A., et al. Granzyme B and the downstream granzymes C and/or F are important for cytotoxic lymphocyte functions. J Immunol 2005, 174(February (4)):2124-2131.
33. Freishtat R.J., Natale J., Benton A.S., Cohen J., Sharron M., Wiles A.A., et al. Sepsis alters the megakaryocyte-platelet transcriptional axis resulting in granzyme B-mediated lymphotoxicity. Am J Respir Crit Care Med 2009, 179(March (6)):467-473.
34. Ross A.G., Sleigh A.C., Li Y., Davis G.M., Williams G.M., Jiang Z., et al. Schistosomiasis in the People's Republic of China: prospects and challenges for the 21st century. Clin Microbiol Rev 2001, 14(April (2)):270-295.
35. Jiang N., Cai P., Yin J., Hao L., Lu H., Wang X., et al. Characterization of antibody responses to the Sj23 antigen of Schistosoma japonicum after infection and immunization. Acta Trop 2010, 116(October (1)):9-14.
36. +T cell responses during infection with the helminth Schistosoma mansoni. J Immunol 1996, 157(October (7)):3046-3053.
37. Kumar P., Ramaswamy K. Vaccination with irradiated cercariae of Schistosoma mansoni preferentially induced the accumulation of interferon-gamma producing T cells in the skin and skin draining lymph nodes of mice. Parasitol Int 1999, 48(August (2)):109-119.
38. Fonteneau J.F., Kavanagh D.G., Lirvall M., Sanders C., Cover T.L., Bhardwaj N., et al. Characterization of the MHC class I cross-presentation pathway for cell-associated antigens by human dendritic cells. Blood 2003, 102(December (13)):4448-4455.
39. Heath W.R., Belz G.T., Behrens G.M., Smith C.M., Forehan S.P., Parish I.A., et al. Cross-presentation, dendritic cell subsets, and the generation of immunity to cellular antigens. Immunol Rev 2004, 199(June):9-26.
40. van Die I., van Vliet S.J., Nyame A.K., Cummings R.D., Bank C.M., Appelmelk B., et al. The dendritic cell-specific C-type lectin DC-SIGN is a receptor for Schistosoma mansoni egg antigens and recognizes the glycan antigen Lewis x. Glycobiology 2003, 13(June (6)):471-478.
41. Storni T., Kundig T.M., Senti G., Johansen P. Immunity in response to particulate antigen-delivery systems. Adv Drug Deliv Rev 2005, 57(January (3)):333-355.
42. Romeih M.H., Hassan H.M., Shousha T.S., Saber M.A. Immunization against Egyptian Schistosoma mansoni infection by multivalent DNA vaccine. Acta Biochim Biophys Sin (Shanghai) 2008, 40(April (4)):327-338.
43. Parlane N.A., Grage K., Mifune J., Basaraba R.J., Wedlock D.N., Rehm B.H., et al. Vaccines displaying mycobacterial proteins on biopolyester beads stimulate cellular immunity and induce protection against tuberculosis. Clin Vaccine Immunol 2012, 19(January (1)):37-44.
44. Mouchacca P., Guyot V., Gregoire C., Schmitt-Verhulst A.M., Boyer C. Granzyme B-tdTomato, a new probe to visualize cytolytic effector cell activation. Eur J Immunol 2012, 42(January (1)):264-266.
45. Sergio C.O., Cristina T.F., Fernanda C.C., Leonardo P.F., Luciana C.C.L. Recent advances in vaccine research against schistosomiasis in Brazil. Acta Trop 2008, 108(June):256-262.